SecurityAMED / Amedisys, Inc.
InstitutionPineBridge Investments, L.P.
Shares46,675
Value $ 2,460,000

PineBridge Investments, L.P. reports 48.11% increase in ownership of AMED / Amedisys, Inc.

February 08, 2018 - PineBridge Investments, L.P. has filed a 13F-HR form disclosing ownership of 46,675 shares of Amedisys, Inc. (NASDAQ:AMED) with total holdings valued at $2,460,000 USD as of December 31, 2017. PineBridge Investments, L.P. had filed a previous 13F-HR on November 13, 2017 disclosing 31,513 shares of Amedisys, Inc. at a value of $1,763,000 USD. This represents a change in shares of 48.11 percent and a change in value of 39.53 percent during the quarter.

Other investors with positions similar to PineBridge Investments, L.P. include Prudential Financial Inc, California State Teachers Retirement System, Arizona State Retirement System, KBC Group NV, Guggenheim Capital Llc, and New York State Common Retirement Fund.

Amedisys, Inc. has declared a standard industrial code (sic) of 8082 which is the "Home Health Care Services" industry. PineBridge Investments, L.P.'s top industries are "Amusement And Recreation Services" (sic 79), "Social Services" (sic 83), and "Agricultural Services" (sic 07).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2017-12-31 13F-HR AMEDISYS INC COM COM 023436108 54.32 46,675 48.11 2,460 39.53 824 -127 -7.19
2017-09-30 13F-HR AMEDISYS INC COM COM 023436108 59.38 31,513 0.04 1,763 -10.91 1 -217 -10.95
2017-06-30 13F-HR AMEDISYS INC COM COM 023436108 56.94 31,501 52.88 1,979 88.12 620 307 29.14
2017-03-31 13F-HR AMEDISYS INC COM COM 023436108 46.84 20,605 42.33 1,052 70.50 287 148 23.98
2016-12-31 13F-HR AMEDISYS INC COM COM 023436108 45.04 14,477 308.95 617 267.26 493 -44 -25.94
2016-09-30 13F-HR AMEDISYS INC COM COM 023436108 49.01 3,540 -0.56 168 -6.67 -1 -11 -6.12
2016-06-30 13F-HR AMEDISYS INC COM COM 023436108 49.42 3,560 2.92 180 7.78 5 8 4.80
2016-03-31 13F-HR AMEDISYS INC COM COM 023436108 43.75 3,459 -8.95 167 12.08 -15 33 22.06
2015-12-31 13F-HR AMEDISYS INC COM COM 023436108 38.69 3,799 -11.59 149 -9.15 -19 4 2.60
2015-09-30 13F-HR AMEDISYS INC COM COM 023436108 38.86 4,297 10.38 164 6.49 16 -6 -3.70
2015-06-30 13F-HR AMEDISYS INC COM COM 023436108 33.13 3,893 -55.37 154 -33.91 -160 81 34.78
2015-03-31 13F-HR AMEDISYS INC COM COM 023436108 28.07 8,723 16.65 233 5.91 35 -22 -9.97
2014-12-31 13F-HR AMEDISYS INC COM COM 023436108 24.77 7,478 4.50 220 52.78 8 68 47.24
2014-09-30 13F-HR/A-1 AMEDISYS INC COM COM 023436108 18.47 7,156 44.98 144 73.49 41 20 24.09
2014-09-30 13F-HR AMEDISYS INC COM COM 023436108 7,156 144
2014-06-30 13F-HR/A-1 AMEDISYS INC COM COM 023436108 15.88 4,936 -37.53 83 -29.66 -47 12 10.23
2014-06-30 13F-HR AMEDISYS INC COM COM 023436108 4,936 83
2014-03-31 13F-HR/A-1 AMEDISYS INC COM COM 023436108 14.83 7,901 -9.11 118 -7.81 -12 2 1.36
2013-12-31 13F-HR/A-1 AMEDISYS INC COM COM 023436108 15.99 8,693 134.31 128 100.00 80 -16 -24.48
2013-09-30 13F-HR/A-1 AMEDISYS INC COM COM 023436108 3,710 64

Related SEC Filings

AMED / Amedisys, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 9 AMEDISYS INC COMMON STOCK Cusip #023436108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #023436108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 269,450 Item 6: 0 Item 7: 998,874 Item 8: 0 Item 9: 998,874 Item 11: 2.943% Item 12: HC Cusip #023436108 Item 1: Reporting Person - Abigail P.

AMED / Amedisys, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 9 AMEDISYS INC COMMON STOCK Cusip #023436108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #023436108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 269,450 Item 6: 0 Item 7: 998,874 Item 8: 0 Item 9: 998,874 Item 11: 2.943% Item 12: HC Cusip #023436108 Item 1: Reporting Person - Abigail P.

AMED / Amedisys, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-12 sec.gov
amedisysinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 7 )*       Name of issuer:  Amedisys Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  023436108     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)

AMED / Amedisys, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-12 sec.gov
amedisysinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 7 )*       Name of issuer:  Amedisys Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  023436108     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)

AMED / Amedisys, Inc. / AMERICAN CENTURY INVESTMENT MANAGEMENT INC - SC 13G (Passive Investment)

2018-02-09 sec.gov
  United States Securities and Exchange Commission Washington, D.C.  20549         SCHEDULE 13G     Under the Securities Exchange Act of 1934     (Amendment No.   )*         AMEDISYS, INC. (Name of Issuer)     COMMON STOCK (Title of Class of Securities)     023436108 (CUSIP Number)       DECEMBER 31, 2017 (Date of Event Which Requires Filing of this Statement)             Check the appropriate box to designate the rule pursuant to which this Schedule is filed:     [ X ] Rule 13d-1(b) [     ] Rul

Related News Stories

Amedisys (AMED) Strong on Home Health, Margin Decline a Woe

2018-02-12 zacks
On Feb 9, we issued an updated research report on Amedisys, Inc. (AMED - Free Report) . The stock carries a Zacks Rank #3 (Hold). (32-0)

Veeva Systems' Product Portfolio Strong, Competition Rife

2018-01-31 zacks
On Jan 30, we issued an updated research report on Veeva Systems (VEEV - Free Report) . Growing demand for cloud-based and vault applications and a diverse product portfolio are key positives. However, the company has been struggling against foreign exchange headwinds and intense competition in niche markets. (55-0)

China’s small banks face uncertainties under new debt rules

2018-01-31 themalaymailonline
Bank of Jilin — Wikipedia Commons picSHANGHAI, Jan 31 — Three years ago, China's Bank of Jilin transformed its business strategy and began to gorge on debt. With a presence in just two provinces in northeast China, its favoured borrowing was short-term loans from other banks.

Abaxis (ABAX) at a 52-Week High: What's Driving the Stock?

2018-01-30 zacks
Shares of Abaxis, Inc. (ABAX - Free Report) scaled a new 52-week high of $78.53 on Jan 29, closing lower at $76. The company has gained 62.7% in the last six months, way higher than the broader industry’s gain of 13.9%. The stock has a market cap of $1.73 billion. Taking the stable stock performance into consideration, we expect Abaxis to scale higher in the coming quarters. Also, the company’s long-term expected earnings growth rate of 4% holds promise. (24-0)

Intuitive Surgical Gains on FDA Approvals, Competition Rife

2018-01-29 zacks
On Jan 26, we issued an updated research report on Intuitive Surgical, Inc. (ISRG - Free Report) . The stock has a Zacks Rank #3 (Hold). (47-1)

Intuitive Surgical (ISRG) Beats on Q4 Earnings & Revenues

2018-01-26 zacks
Intuitive Surgical Inc (ISRG - Free Report) posted adjusted earnings of $2.54 per share in the fourth quarter of 2017, which beat the Zacks Consensus Estimate of $2.27 and improved 25.1% year over year. (37-0)

LPC: US CLOs may see record year as investors seek interest-rate hedge

2018-01-10 reuters
NEW YORK, Jan 10 (Reuters) - The US Collateralized Loan Obligation (CLO) market may be heading for a record year in 2018 as investors seek floating-rate assets as a hedge to rising interest rates. (28-0)

PSP / PowerShares Exchange-Trade Fund Trust - Stock Institutional Ownership and Shareholders - Fintel.io

2018-01-10 fintel.io
PowerShares Exchange-Trade Fund Trust (NYSE:PSP) has 71 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12,075,178 shares. Largest shareholders include Wells Fargo & Company/mn, PineBridge Investments, L.P., Amerivest Investment Management LLC, Morgan Stanley, Bank Of America Corp /de/, Beacon Capital Management, Inc. (162-0)

Emerging markets sailed through storms in 2017. What next?

2018-01-03 bworldonline
LONDON — After a year of double-digit returns, one of the key questions for emerging markets in 2018 is whether they will continue to be insulated from one another’s crises. (1-0)

Analysis: Emerging markets sailed through storms in 2017. What next?

2018-01-02 in.reuters
LONDON (Reuters) - After a year of double-digit returns, one of the key questions for emerging markets in 2018 is whether they will continue to be insulated from one another’s crises.




CUSIP: 023436108